TORM plc – Notice of and complete proposals for the Annual General Meeting 2024
Please find enclosed the notice of and the complete proposals for the Annual General Meeting of TORM plc to be held on 11 April 2024.
Contacts
Christopher H. Boehringer, Chairman, tel.: +45 3917 9200
Jacob Meldgaard, Chief Executive Officer and Executive Director, tel.: +45 3917 9200
Christopher Everard, General Manager, tel.: +44 7920 494 853
Kim Balle, Chief Financial Officer, tel.: +45 3917 9200
About TORM
TORM is one of the world’s leading carriers of refined oil products. TORM operates a fleet of approximately 90 product
tanker vessels with a strong commitment to safety. environmental responsibility and customer service. TORM was founded
in 1889 and conducts business worldwide. TORM’s shares are listed on Nasdaq in Copenhagen and on Nasdaq in New York
(ticker: TRMD A and TRMD. ISIN: GB00BZ3CNK81). For further information. please visit www.torm.com.
Safe harbor statements as to the future
Matters discussed in this release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements reflect our current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are statements other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. Words such as, but not limited to, “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “targets,” “projects,” “forecasts,” “potential,” “continue,” “possible,” “likely,” “may,” “could,” “should” and similar expressions or phrases may identify forward-looking statements.
The forward-looking statements in this release are based upon various assumptions, many of which are, in turn, based upon further assumptions, including without limitation, management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although the Company believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies that are difficult or impossible to predict and are beyond our control, the Company cannot guarantee that it will achieve or accomplish these expectations, beliefs, or projections.
Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to, our future operating or financial results; changes in governmental rules and regulations or actions taken by regulatory authorities; the central bank policies intended to combat overall inflation and rising interest rates and foreign exchange rates; inflationary pressure; increased cost of capital or limited access to funding due to EU Taxonomy or relevant territorial taxonomy regulations; [the length and severity of epidemics and pandemics and their impact on the demand for seaborne transportation of petroleum products;] general domestic and international political conditions or events, including “trade wars”, and the conflict between Russia and Ukraine, the developments in the Middle East, including the conflicts in Israel and the Gaza Strip, and the conflict regarding the Houthi’s attack in the Red Sea; changes in economic and competitive conditions affecting our business, including market fluctuations in charter rates and charterers’ abilities to perform under existing time charters; changes in the supply and demand for vessels comparable to ours and the number of newbuildings under construction; the highly cyclical nature of the industry that we operate in; the loss of a large customer or significant business relationship; changes in worldwide oil production and consumption and storage; risks associated with any future vessel construction; our expectations regarding the availability of vessel acquisitions and our ability to complete acquisition transactions planned; availability of skilled crew members other employees and the related labor costs; work stoppages or other labor disruptions by our employees or the employees of other companies in related industries; the impact of increasing scrutiny and changing expectations from investors, lenders and other market participants with respect to our ESG policies; Foreign Corrupt Practices Act of 1977 or other applicable regulations relating to bribery; effects of new products and new technology in our industry, including the potential for technological innovation to reduce the value of our vessels and charter income derived therefrom; new environmental regulations and restrictions, whether at a global level stipulated by the International Maritime Organization, and/or imposed by regional or national authorities such as the European Union or individual countries; the impact of an interruption in or failure of our information technology and communications systems, including the impact of cyber-attacks, upon our ability to operate; potential conflicts of interest involving members of our board of directors and senior management; the failure of counterparties to fully perform their contracts with us; changes in credit risk with respect to our counterparties on contracts; our dependence on key personnel and our ability to attract, retain and motivate key employees; adequacy of insurance coverage; our ability to obtain indemnities from customers; changes in laws, treaties or regulations; our incorporation under the laws of England and Wales and the different rights to relief that may be available compared to other countries, including the United States; government requisition of our vessels during a period of war or emergency; the arrest of our vessels by maritime claimants; any further
changes in U.S. trade policy that could trigger retaliatory actions by the affected countries; potential disruption of shipping routes due to accidents, climate-related incidents, environmental factors, political events, public health threats, acts by terrorists or acts of piracy on ocean-going vessels; the impact of adverse weather and natural disasters; damage to storage and receiving facilities; potential liability from future litigation and potential costs due to environmental damage and vessel collisions; and the length and number of off-hire periods and dependence on third-party managers. In the light of these risks and uncertainties, undue reliance should not be placed on forward-looking statements contained in this release because they are statements about events that are not certain to occur as described or at all. These forward-looking statements are not guarantees of our future performance, and actual results and future developments may vary materially from those projected in the forward-looking statements. Except to the extent required by applicable law or regulation, the Company undertakes no obligation to release publicly any revisions or updates to these forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events. Please see TORM’s filings with the U.S. Securities and Exchange Commission for a more complete discussion of certain of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication.
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. IT CONTAINS PROPOSALS RELATING TO TORM PLC (THE "COMPANY") ON WHICH YOU ARE BEING ASKED TO VOTE.
The definitions used throughout this Circular are set out on pages 11 and 12 of this Circular.
If you are in any doubt about the contents of this document or the action you should take, you are recommended to immediately seek your own personal financial advice from an appropriately qualified independent adviser authorized pursuant to the Financial Services and Markets Act 2000 if in the United Kingdom or otherwise regulated under the laws of your own country.
If you sell or transfer or have sold or transferred all your shares in the Company, you should hand this Circular and the documents accompanying it to the purchaser or agent through whom the sale was effected for transmission to the purchaser. If you sell or have sold or otherwise transferred only part of your holding of shares, you should retain these documents.
TORM PLC
(a company registered in England and Wales with company number 09818726)
Notice of Annual General Meeting
This document should be read in its entirety. Your attention is drawn to the letter from the Chairman of the Company set out in this document, which contains your Board's unanimous recommendation to vote in favor of the Resolutions set out in the notice of Annual General Meeting referred to below.
Notice of the Annual General Meeting (the "AGM") of the Company to be held at the Company’s offices at Suite 105
20 St. Dunstan’s Hill, London, EC3R 8HL, United Kingdom on 11 April 2024 at 12:00 noon (BST) is set out at the end of this Circular.
Shareholders will find enclosed a Form of Proxy for use at the AGM. To be valid for use at the AGM, the Form of Proxy must be completed and returned, in accordance with the instructions printed thereon, to the Company's registered office as soon as possible and, in any event, to arrive by 18:00 (BST) on 09 April 2024. The completion and return of a Form of Proxy will not preclude shareholders from attending and voting in person at the AGM, should they subsequently wish to do so.
Shareholders have the option to dial in to the AGM via Q4, rather than attend in person, and to vote on all Resolutions in advance of the AGM by completing their Form of Proxy. Shareholders have the option to appoint the Chairman of the AGM or any named individual to act as their proxy to ensure their votes are duly cast.
YOU ARE REQUESTED TO COMPLETE AND RETURN THE ENCLOSED FORM OF PROXY IN ACCORDANCE WITH THE INSTRUCTIONS HEREIN.
Your attention is drawn to the section entitled "Action to be taken by shareholders" on page 8 of this Circular.
This document will be available for download from the Company's website at www.torm.com
LETTER FROM THE CHAIRMAN
TORM PLC
(Registered in England and Wales with Company Number 09818726)
Registered Office:
Suite 105
20 St. Dunstan’s Hill London
EC3R 8HL
United Kingdom
Directors:
Christopher H. Boehringer, Chairman David N. Weinstein, Deputy Chairman Jacob Meldgaard, Executive Director Annette Malm Justad
Göran Trapp
07 March 2024
Dear Shareholder
NOTICE OF ANNUAL GENERAL MEETING
1 Introduction
I am writing in connection with the Resolutions to be proposed at the forthcoming Annual General Meeting ("AGM") of TORM Plc (the "Company") at 12:00 noon (BST) on 11 April 2024 at the Company’s offices at 20 St. Dunstan’s Hill, London EC3R 8HL, United Kingdom. Your attention is drawn to the recommendations of the Board as set out in paragraph 7 of this letter.
In particular, I am writing to provide you with details of the proposed Capital Reduction which will enhance the Company’s ability to return surplus capital, undertake share buy-backs and pay dividends to shareholders in the future.
The Directors of the Company have taken all reasonable care to ensure that the facts stated in this Circular are true and accurate in all material aspects, and that there are no material facts the omission of which would make misleading any statement contained in this Circular, whether of fact or opinion.
The Definitions section on pages 11 and 12 of this Circular contains definitions of words and terms that have been used. Please refer to this section as you review this Circular.
2 Capital Reduction
Background to, and reasons for, the Capital Reduction
The purpose of this Document is to provide you with information about the Capital Reduction and to explain why the Board considers the Capital Reduction to be in the best interests of the Company and its Shareholders as a whole and unanimously recommends that you vote in favor of the Resolutions to be proposed at the Annual General Meeting. Shareholders should note that, unless Resolution 14 is approved at the Annual General Meeting (and the Court subsequently confirms the Capital Reduction), the Capital Reduction will not take place.
The Company is not permitted to undertake share buy-backs nor pay any dividends unless it has distributable reserves. The Share Premium Account only has limited applications and, accordingly, the Company is proposing to reduce its Share Premium Account by USD 320m, in order to create further distributable reserves to support: (i) the future payment by the Company of dividends to its shareholders; and (ii) share buy-backs should circumstances dictate it desirable.
In light of the Group’s prospects and current strong financial position, the Directors believe it is now desirable to consider future potential share buy-backs or payment of dividends to shareholders.
Upon completion of the Capital Reduction, the Company’s Share Premium Account will be reduced by USD 320m.
The completion of the Capital Reduction will not affect the rights attached to the shares and will not result in any change to the number of shares (or their nominal value).
Shareholder Approval
In order to effect the Capital Reduction, the Company requires the approval of its shareholders pursuant to section 641(1)(b) of the Companies Act. The Capital Reduction cannot be effected unless the Company receives the approval by the requisite majority of shareholders and in the requisite manner as set out in this section of the Circular.
The holders of the A-shares and the B-share, are entitled to receive notice of, attendance, speak and vote at the AGM pursuant to the Articles of Association. The votes of the holders of the A-shares and the B-share will be added together at the AGM and the Resolution to approve the Capital Reduction, which will be proposed as a special resolution, requires a majority in favor of at least 75% of the votes cast by the shareholders attending and voting in person or by proxy in order to be passed.
The holder of the C-share is not entitled to vote on the resolution relating to the Capital Reduction pursuant to the Articles of Association. The proposed Capital Reduction does not alter the rights attaching to the C-share and therefore the Company does not require the approval of the holder of the C-share.
Court Approval
In addition to the approval by the shareholders of the relevant Resolution, the Capital Reduction requires the approval of the Court. Accordingly, following the Annual General Meeting, an application will be made to the Court in order to confirm and approve the Capital Reduction.
The Board is satisfied that there is no real likelihood that the Capital Reduction would result in the Company being unable to discharge a creditor’s debt or claim when it falls due. The Company has obtained letters of consent to the Capital Reduction from its major finance providers and other major creditors.
It is anticipated that the initial directions hearing in relation to the Capital Reduction will take place on 01 May 2024, with the final Court Hearing taking place on 14 May 2024 and the Capital Reduction becoming effective following the necessary registration of the Court Order at Companies House.
The Capital Reduction itself will not involve any distribution or repayment of capital or share premium by the Company and will not reduce the underlying net assets of the Company. Pursuant to Part 23 of the Companies Act, the distributable reserves arising on the Capital Reduction will, subject to the discharge of any undertakings required by the Court, support the Company’s ability to undertake share buy-backs or pay dividends, should circumstances in the future make it desirable to do so.
The Board reserves the right to abandon or discontinue (in whole or in part) the application to the Court in the event that the Board considers that the terms on which the Capital Reduction would be (or would be likely to be) confirmed by the Court would not be in the best interests of the Company and/or its shareholders as a whole. The Board has undertaken a thorough and extensive review of the Company’s liabilities (including contingent liabilities) and considers that the Company will be able to satisfy the Court, as at the date (if any) on which the Court Order relating to the Capital Reduction and the statement of capital in respect of the Capital Reduction have both been registered by the Registrar of Companies at Companies House and the Capital Reduction will therefore become effective and, the Company’s creditors will be sufficiently protected.
3 Explanatory notes to the notice of the AGM
The following notes explain the proposed Resolutions. Resolutions 1 to 11 are proposed as Ordinary Resolutions. For each of those resolutions to be passed, more than half of the votes cast must be in favor of the resolution. Resolutions 12 to 14 are proposed as special resolutions, which to be passed, at least three-quarters of the votes cast must be in favor of the resolutions.
Resolution 1 – Annual Report and Accounts
The Directors must present the audited annual accounts and the Directors' and Auditor’s report for the financial year ended 31 December 2023. A copy of the Directors' and Auditor’s reports and the financial statements are available on the Company's website (www.torm.com).
Resolutions 2 and 3 – Remuneration report and Remuneration Policy
The Company's shareholders will be asked to approve the remuneration report at the AGM.
The Remuneration Policy, approved by the shareholders at the AGM on 14 April 2021, took effect from the date of that meeting. As of the date of this Annual Report, TORM plc is in compliance with the requirements of this Remuneration Policy. During 2023, the Nomination Committee reviewed the policy and agreed that it should remain broadly unchanged except for the following proposed amendments:
- The removal of paid fees for Board observers; and
- Preparation of the policy in English only
During 2023 the Nomination Committee reviewed the Articles of Association to understand if there was an obligation to pay fees to the B Shareholder Board Observer. It was noted that there was only an obligation to reimburse for reasonable travel, hotel and incidental expenses of the Board Observers incurred in attending and returning from meetings. It was therefore decided that the payment of fees should be removed as they had previously been removed from the TORM elected Board Observers.
The Remuneration Policy has previously been prepared in both Danish and English and it has been decided to prepare the policy in English only going forward.
Resolutions 4 and 5 – Reappointment and remuneration of auditors
The Company must appoint auditors at each general meeting at which accounts are presented to shareholders to hold office until the conclusion of the next such meeting. Resolution 4 seeks shareholder approval to reappoint Ernst & Young LLP as the Company's auditors.
In accordance with normal practice, Resolution 5 seeks authority from the Company's Directors to fix their remuneration.
Resolution 6 – Approval of final dividend
The Company’s shareholders will be asked to approve a final dividend. Section 6 below sets out more detail on the proposed dividend.
Resolutions 7 to 10 – Reappointment of Directors
The Company’s Articles of Association require every Director, other than the B-director, to retire at the end of the first AGM after their appointment and at each subsequent AGM. Christopher H. Boehringer, Annette Malm Justad, Göran Trapp and Jacob Meldgaard are standing for reappointment in accordance with these provisions.
The biographical details of all Directors can be found on the Company’s website at https://www.torm.com/about/leadership/board-of-directors/default.aspx
Resolution 11 – Renewal of Existing Allotment Authorities
On 15 April 2020, the Company passed the Existing Allotment Authorities, being the authorities given by shareholders to the Directors to offer equity securities of the Company. The Existing Allotment Authorities are due to expire on 14 April 2025 and it is proposed to extend these authorities for a period of five years.
Article 8.4 of the Company’s Articles of Association allow the extension of the Existing Allotment Authorities.
Set out below is a summary of the Existing Allotment Authorities that were passed on 15 April 2020, along with how much of these authorities remain and are to be renewed and extended.
The Directors were given authority to allot A-shares in the Company and grant rights to subscribe for or convert any security into the shares in the Company:
(A) up to an aggregate nominal amount of USD 1,372,283 and which is offered in connection with an initial public offering of equity securities on the New York Stock Exchange, the NYSE MKT LLC or the NASDAQ Stock Market (each, a “US Market”) and/or an underwritten follow on offering of equity securities on a US Market and/or a private placement of equity securities to be listed on a US Market (together, the “US Offerings”). At a nominal value of USD 0.01 this equates to 137,228,300 A-shares. No A-shares have been allotted or issued by the Company under this authority to date and it is proposed that this authority is renewed and extended in full.
(B) up to an aggregate nominal amount of USD 5,073,293 and which are:
(i) offered to holders of A-shares in proportion to their existing holdings of A-shares and to other shareholders as required or as the Board otherwise considers necessary; or
(ii) allotted or issued at fair value (taking account of any relevant part of the subscription or acquisition price for such securities) and where fair value is determined by the Board in its sole discretion based upon International Accounting Standards (and which may represent a discount to the price at which the Company’s A-shares are trading or have traded on any exchange or market).
The Company has issued 13,182,836 A-shares under this authority. Therefore, at a nominal value of USD 0.01, the Company has a remaining authority of 494,146,464 A-shares under this authority. This does not include the shares the Company has contractually agreed to issue as the exact number of these shares will depend on various factors at the time of issue. It is proposed that this remaining authority is renewed and extended in full.
(C) up to an aggregate nominal amount of USD 777,625 and which are allotted to Directors, officers or employees of the Company or any of its subsidiary undertakings (or to any trust, company or other entity established to benefit such persons). The Company has issued 2,785,850 A-shares under this authority and the Company has granted share options over a further 4,274,162 A- shares under this authority. For further information, please see the Remuneration Report and, in particular, page 116 of the Annual Report. Therefore, at a nominal value of USD 0.01, the Company has a remaining authority of 70,702,488 A-shares under this authority. It is proposed that this remaining authority is renewed and extended in full.
Resolution 12 – Renewal of Existing Disapplication Authorities
Under company law, when new shares are allotted or treasury shares are sold for cash, they must generally first be offered to existing shareholders pro rata to their holdings.
On 15 April 2020, the Company passed the Existing Disapplication Authorities, being the authorities given by shareholders to the Directors to offer equity securities of the Company without first offering them to existing A-shareholders. The Existing Disapplication Authorities are due to expire on 14 April 2025 and it is proposed to extend these authorities for a period of five years.
Article 8.4 of the Company’s Articles of Association allow the extension of the Existing Disapplication Authorities.
The Existing Disapplication Authorities mirror the Existing Allotment Authorities in form and below is a summary of the Existing Disapplication Authorities that were passed on 15 April 2020, along with how much of these authorities remain and are to be renewed and extended.
(A) The authority in connection with US Offerings covers the full authority to be renewed and extended under Resolution 12. It is proposed that this authority is renewed and extended in full.
(B) The authority in connection with the authority set out under (B)(ii) of Resolution 11 was up to an aggregate nominal amount of USD 2,477,026. The Company has issued 13,182,836 A-shares under this authority, therefore, at a nominal value of USD 0.01, the Company has a remaining authority of 234,519,764 A-shares under this authority. This does not include the shares the Company has contractually agreed to issue as the exact number of these shares will depend on various factors at the time of issue. It is proposed that this remaining authority is renewed and extended in full.
(C) The authority in connection with the authority set out under (C) of Resolution 11 covers the full authority to be renewed and extended under Resolution 12. It is proposed that this authority is renewed and extended in full.
Resolution 13 – Authority for market purchases of own shares
Resolution 13 renews the Company’s authority to make limited market purchases of the Company’s A-shares. This authority is limited to a maximum aggregate number of 18,145,867 A-shares representing 20% of the issued share capital of the Company as of 28 February 2024 (being the latest practicable date prior to publication of this notice) and sets out the minimum and maximum prices that can be paid, exclusive of expenses. The authority conferred by this resolution will expire on 10 April 2029.
The Directors have no present intention of exercising the authority to purchase the Company’s A-shares but will keep the matter under review.
Resolution 14 – Capital Reduction
As outlined above, this is a special resolution to reduce the Share Premium Account of the Company by USD 320,000,000.00.
4 Dial-in option
Shareholders have the option to dial in to the AGM via the Q4 access, rather than attend in person, and to vote on all Resolutions in advance of the AGM by completing their Form of Proxy. Please complete the Form of Proxy sent to you with this notice and return it to our registrars as soon as possible.
Shareholders are invited to submit any questions on the business of the meeting in advance of the AGM to [email protected] no later than 18:00 (BST) on 05 April 2024, and we will provide them with written answers.
Shareholders can follow the proceedings of the AGM by accessing an online audio and presentation link, accessible via the following link:
Webcast Audience URL:
https://events.q4inc.com/attendee/572098226
The online presentation link will be opened at approximately 11:55 a.m. on 11 April 2024. However, please note that shareholders will not be able to vote at the AGM via the online presentation link.
5 Expenses
The costs and expenses of calling the AGM and any adjourned AGM will be met by the Company. The costs will be paid by the Company irrespective of whether or not the Resolutions are passed by the requisite majority at the forthcoming AGM.
6 Dividend
According to the Company’s Distribution Policy, the Company intends to declare a quarterly dividend based on the cash position at the end of each quarter. The Board is recommending a final dividend for the financial year ended 31 December 2023 of USD 1.36 per A-share. When taking into account share issuances that are expected to take place prior to the dividend record date, this is expected to equate to an aggregate dividend payment of USD 126.3m. This dividend is expected to be paid on 24 April 2024 to all shareholders appearing on the register of members as of 16 April 2024. The payment of the dividend is not conditional on the proposed Capital Reduction.
7 Recommendations
The Board believes that the approval of the Resolutions to be proposed at the AGM is in the best interests of the shareholders as a whole and recommends that the shareholders vote in favor of the Resolutions set out in the notice of AGM of the Company, as the Directors intend to do, or procure to be done, in respect of their own and their related parties' beneficial holdings.
8 Action to be taken by shareholders
a) Annual General Meeting
The Resolutions are subject to shareholder approval. A notice convening the AGM is set out at the end of this Circular.
A Form of Proxy for the AGM is enclosed with this Circular, and you are requested to complete and post the Form of Proxy to the Company's registered address as soon as possible. The completion and return of a Form of Proxy will not prevent you from attending the AGM in person, speaking and voting if you wish to do so.
To be valid, an instrument appointing a proxy and any power of attorney or other authority under which the proxy instrument is signed (or a notarially certified copy thereof) must be deposited at the Company address as the case may be by 18:00 (BST) on 09 April 2024.
For those shareholders who hold shares via Euronext Securities and which are trading on Nasdaq in Copenhagen, you may vote or register electronically at www.euronext.com/cph-agm no later than 09 April 2024 by 18:00 (BST). Alternatively, you may return a proxy instruction form or registration form. The dated and signed form must reach Euronext Securities by 09 April 2024 by 18:00 (BST) either by e-mail ([email protected]) or by ordinary mail to Euronext Securities, Nicolai Eigtveds Gade 8, 1402 Copenhagen K, Denmark.
Shareholders who hold shares traded on Nasdaq in New York should return the voting instructions as indicated on the Voter Instruction Form.
The majority required for the passing of the Ordinary Resolutions at the AGM is a simple majority of the total number of votes cast.
The quorum for the AGM is two or more shareholders who are entitled to vote, present in person or by proxy or a duly authorized representative of a corporation which is a member. If, within five minutes after the time appointed for the AGM (or such longer interval not exceeding one hour as the Chairman may consider fit to allow), a quorum is not present, the AGM shall stand adjourned to a day (but not less than ten days later, excluding the day on which the meeting is adjourned and the day for which it is reconvened), time and place to be decided by the Chairman, and at such adjourned meeting, one member present in person or by proxy and entitled to vote will constitute a quorum.
b) Inspection of documents
Copies of the following documents will be available for inspection at the Registered Office of the Company during normal business hours on any business day from the date of this Circular until the conclusion of the AGM and at the place of the AGM for at least 15 minutes prior to, and during, the AGM:
(i) The Articles of Association of the Company
(ii) This Circular
(iii) A memorandum setting out the terms of the contracts for services of the Executive Director and each of the non-Executive Directors
c) Other available documents
The Annual Report and accounts for the financial year ended 31 December 2023 and a Proxy Statement will be available to view and download from the Company’s website at https://www.torm.com/investors/reports-and- presentations/financial-reports/default.aspx.
If you have questions in this regard, please do not hesitate to contact Christopher Everard at tel. +44 7920 494 853.
Yours faithfully
Christopher H. Boehringer
Chairman of the Board of Directors
EXPECTED TIMETABLE
Deadline for submission of questions related to 18:00 (BST) on 05 April 2024 the Annual General Meeting
Deadline for receipt of Forms of Proxy 18:00 (BST) on 09 April 2024 for the Annual General Meeting
Time and date of Annual General Meeting 12:00 noon (BST) on 11 April 2024
Expected Effective Time of the Resolutions 12:00 noon (BST) on 11 April 2024*
Expected Date of Court Hearing to confirm
the Capital Reduction 14 May 2024
*(or, if later, the effective time and date upon which shareholders approve the Resolutions).
1. Each of the times and dates listed above and elsewhere in this document are indicative and accordingly subject to change.
2. The expected dates for the confirmation of the Capital Reduction by the Court and the Capital Reduction becoming effective are based on provisional dates that have been obtained for the required Court hearings of the Company’s application. These provisional hearing dates are subject to change and dependent on the Court’s timetable.
3. If any of the details contained in the timetable above should change, the revised times and dates will be notified to the shareholders by means of an announcement through a Regulatory Information Service.
4. References to time in this document are to London time unless otherwise stated.
5. All events listed in the above timetable following the AGM are conditional on the passing of the Resolutions contained in the Notice of the Annual General Meeting, at the AGM.
DEFINITIONS
The following definitions apply throughout this Circular unless the context requires otherwise:
|
AGM or Annual General Meeting |
The Annual General Meeting of the Company to be held on 11 April 2024 (or any adjournment thereof), notice of which is set out at the end of this Circular. |
|
Articles of Association |
The Articles of Association of the Company adopted by special resolution on 15 March 2016 and amended by special resolution on 14 April 2021. |
|
A-shares |
The A-shares of USD 0.01 each in the capital of the Company. |
|
Board of Directors, the Board or the Directors |
The Board of Directors of the Company. |
|
B-share |
The B-share of USD 0.01 in the capital of the Company. |
|
BST |
British Summer Time. |
|
Business day |
Any day other than a Saturday or Sunday on which banks are open for normal banking business in London. |
|
Capital Reduction |
The proposed reduction of the Company’s Share Premium Account as set out in the Notice of the Annual General Meeting. |
|
Circular or Document |
This document including, for the avoidance of doubt, the Letter from the Chairman, Notice of Annual General Meeting and the Form of Proxy. |
|
Companies Act |
The Companies Act 2006, as amended, supplemented or replaced from time to time. |
|
Company |
TORM plc. |
|
C-share |
The ordinary C-share of USD 0.01 in the capital of the Company. |
|
Effective time |
The time at which the Resolutions are expected to become effective, being 12:00 noon (BST) on 11 April 2024 or such other time as the Directors may in their absolute discretion determine. |
|
Euronext Investor Services |
Euronext Securities (www.euronext.com) administers the shared listed on Nasdaq in Copenhagen. |
|
Form of Proxy |
The Form of Proxy appended to this Circular for the use of the shareholders in voting at the AGM. |
|
Nasdaq in Copenhagen |
The stock exchange known as Nasdaq in Copenhagen where the shares are listed and available for trade. |
|
Nasdaq in New York |
The stock exchange known as Nasdaq in New York where the shares are listed and available for trade. |
|
Notice of the Annual General Meeting or Notice of the AGM |
The notice convening the AGM, which is set out at the end of this Circular. |
|
Ordinary Resolutions |
The Ordinary Resolutions to be proposed at the AGM which are set out in the notice convening the AGM at the end of this Circular. |
|
Registered office |
Suite 105, 20 St Dunstan’s Hill, London EC3R 8HL, United Kingdom. |
|
Resolutions |
The resolutions to be proposed at the AGM which are set out in the notice convening that meeting at the end of this Circular. |
|
Share Premium Account |
The share premium account of the Company. |
|
Shares |
As the context indicates, the A-shares, the B-share and the C-share of USD 0.01 in the capital of the Company. |
|
Shareholders |
Holders of shares. |
|
Special Resolution |
The special resolution to be proposed at the AGM which is set out in the notice convening the AGM at the end of this Circular. |
TORM PLC
Registered in England and Wales – Company Number 09818726 (the "Company")
NOTICE OF ANNUAL GENERAL MEETING
NOTICE IS HEREBY GIVEN that the Annual General Meeting of the Company will be held at the Company’s offices at Suite 105, 20 St Dunstan’s Hill, London EC3R 8HL, United Kingdom, on Thursday, 11 April 2024 at 12:00 noon (BST).
To consider and, if thought appropriate, pass the following Resolutions which will be proposed as ordinary and special resolutions as set out below:
Ordinary Resolutions
- THAT the Company’s Annual Report and accounts for the financial year ended 31 December 2023 (the “Annual Report”), together with the Directors’ report and the Auditor’s report on those accounts, be received and adopted.
- THAT the Company's Remuneration Report, as set out on pages 110 to 121 of the Company’s Annual Report, be approved together with the Auditor’s report on it.
- THAT the Company’s Remuneration Policy as set out on pages 122 to 130 of the Company’s Annual Report be approved.
- THAT Ernst & Young LLP be reappointed as auditor of the Company to hold office from the conclusion of this meeting until the conclusion of the next general meeting of the Company at which accounts are laid.
- THAT the Directors be authorized to fix the remuneration of the auditors.
- THAT the Company declare a final dividend for the year ended 31 December 2023 of USD 1.36 per A-share to be paid to the holders the A-shares on the register of members at the close of business on 16 April 2024.
- THAT the Company’s Non-Executive Director and Chairman, Christopher H. Boehringer, is reappointed as Director of the Company.
- THAT the Company’s Non-Executive Director, Göran Trapp, is reappointed as Director of the Company.
- THAT the Company’s Non-Executive Director, Annette Malm Justad, is reappointed as Director of the Company.
- THAT the Company’s Executive Director, Jacob Meldgaard, is reappointed as Director of the Company.
- THAT, in accordance with Article 8.4 of the Articles of Association, the Existing Allotment Authorities (as such term is defined in the Articles of Association) be renewed and extended in their entirety (other than the authority to allot A-shares in relation to the Exchange Offer, as such term is defined in the Existing Allotment Authorities) so as to apply until the close of business on 10 April 2029 (unless renewed, revoked or varied in general meeting) and so that, for the purposes of sub-paragraph (B) of the Existing Allotment Authorities (as hereby renewed and extended) “USD 5,073,293” shall read “USD 4,941,464.64 (less the nominal amount of any A-shares allotted, or rights to subscribe for or to convert securities into A-shares granted, pursuant to the Existing Allotment Authorities between the date of the notice of this resolution and the date of approval thereof)” and, for the purposes of sub-paragraph (C) of the Existing Allotment Authorities (as hereby renewed and extended) “USD 777,625” shall read “USD 707,024.88 (less the nominal amount of any A-shares allotted, or rights to subscribe for or to convert securities into A-shares granted, pursuant to the Existing Allotment Authorities between the date of the notice of this resolution and the date of approval thereof, other than pursuant to rights granted prior to the date of the notice of this resolution)”but, in each case, during this period the Company may make offers and enter into agreements which would, or might, require A-shares to be allotted or rights to subscribe for or to convert securities into A-shares to be granted after the authority ends and the Board may allot shares or grant rights to subscribe for or to convert securities into A-shares under any such offer or agreement as if the authority had not ended.
Special Resolutions
- THAT, in accordance with Article 8.4 of the Articles of Association and subject to the passing of Resolution 11, the Existing Disapplication Authorities (as such term is defined in the Articles of Association) be renewed and extended in their entirety so as to apply until the close of business on 10 April 2029 (unless renewed, revoked or varied in general meeting) and so that, for the purposes of sub-paragraph (B) of the Existing Disapplication Authorities (as hereby renewed and extended) “USD 2,477,026” shall read “USD 2,345,197.64 (less the nominal amount of any A-shares allotted, or rights to subscribe for or to convert securities into A-shares granted, pursuant to the Existing Disapplication Authorities between the date of the notice of this resolution and the date of approval thereof)” and, for the purposes of sub-paragraph (C) of the Existing Disapplication Authorities (as hereby renewed and extended) “USD 777,625” shall read “USD 707,024.88 (less the nominal amount of any A-shares allotted, or rights to subscribe for or to convert securities into A-shares granted, pursuant to the Existing Disapplication Authorities between the date of the notice of this resolution and the date of approval thereof, other than pursuant to rights granted prior to the date of the notice of this resolution)” but, in each case, during this period the Company may make offers and enter into agreements which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends, and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the power had not ended.
- THAT:
13.1. the Company be, and it is hereby, generally and unconditionally authorized for the purpose of sections 693 and 701 of the Companies Act 2006 to make one or more market purchases (within the meaning of section 693(4) of the Companies Act 2006) of it’s A-shares upon such terms and in such manner as the Directors of the Company shall determine, provided that:
13.1.1. the maximum aggregate number of A‐shares authorized to be purchased is 18,145,867;
13.1.2. the minimum price which may be paid for such A-shares is USD 0.01 per share (exclusive of expenses);
13.1.3. the maximum price (exclusive of expenses) which may be paid for an A-share cannot be more than the higher of:
i) An amount equal to 5% above the average market value of an A-share for the five business days immediately preceding the day on which that A-share is contracted to be purchased; and
ii) The higher of the price of the last independent trade and the highest current independent bid on the trading venues where the purchase is carried out;
13.1.4. unless previously renewed, varied or revoked, the authority hereby conferred shall expire at the close of business on 10 April 2029 but so that the company may enter into a contract to purchase A-shares which will or may be completed or executed wholly or partly after the power ends and the company may purchase A-shares pursuant to any such contract as if the power had not ended.
- THAT the share premium account of the Company be reduced by USD 320,000,000.00.
By order of the Board
Christopher H. Boehringer
Chairman of the Board of Directors
Dated 07 March 2024
Registered Office: Suite 105, 20 St Dunstan’s Hill, London EC3R 8HL, United Kingdom.
Notes:
(a) Only those shareholders registered in the Company's register of members at:
(i) 18:00 (BST) on 09 April 2024; or,
(ii) if this meeting is adjourned, at 18:00 (BST) on the day two days prior to the adjourned meeting,
shall be entitled to attend, speak and vote at the meeting. Changes to the register of members after the relevant deadline shall be disregarded in determining the rights of any person to attend and vote at the meeting.
(b) Information regarding the meeting, including the information required by section 311A of the Companies Act 2006, can be found at www.torm.com.
(c) If you wish to attend the meeting in person, please attend the Company’s office at Suite 105, 20 St Dunstan’s Hill, London EC3R 8HL, United Kingdom on 11 April 2024 at 12:00 noon (BST).
(d) If you are a shareholder who is entitled to attend and vote at the meeting, you are entitled to appoint one or more proxies to exercise all or any of your rights to attend, speak and vote at the meeting, and you should have received a proxy form with this notice of meeting. A proxy does not need to be a shareholder of the Company but must attend the meeting to represent you. You can only appoint a proxy using the procedures set out in these notes and the notes to the Proxy Form. To appoint more than one proxy, please contact the Company on tel. +44 203 795 2794.
(e) To be valid, an instrument appointing a proxy and any power of attorney or other authority under which the proxy instrument is signed (or a notarially certified copy thereof) must be deposited at the Company's registered office by 18:00 (BST) on 09 April 2024.
(f) The completion and return of a Proxy Form will not affect the right of a member to attend, speak and vote in person at the meeting convened by this notice. If you have appointed a proxy and attend the meeting in person, your proxy appointment will automatically be terminated.
(g) A vote withheld is not a vote in law, which means that the vote will not be counted in the calculation of votes for or against the resolution. If no voting indication is given, your proxy will vote or abstain from voting at his or her discretion. Your proxy will vote (or abstain from voting) as he or she thinks fit in relation to any other matter which is put before the meeting.
(h) In the case of joint holders, where more than one of the joint holders completes a proxy appointment, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear in the Company's register of members in respect of the joint holding (the first-named being the most senior).
(i) Shareholders may change proxy instructions by submitting a new proxy appointment using the methods set out above. Note that the cut-off time for receipt of proxy appointments also applies in relation to amended instructions; any amended proxy appointment received after the relevant cut-off time will be disregarded.
(j) If you submit more than one valid proxy appointment, the appointment received last before the latest time for the receipt of proxies will take precedence.
(k) A shareholder may change a proxy instruction, but to do so you will need to inform the Company in writing by either:
(i) sending a signed hardcopy notice clearly stating your intention to revoke your proxy appointment to the Company. In the case where a shareholder is a company, the revocation notice must be executed under its common seal or signed on its behalf by an officer of the company or an attorney for the company. Any power of attorney or any other authority under which the revocation notice is signed (or a duly certified copy of such power or authority) must be included with the revocation notice; or
(ii) sending an email to [email protected].
(l) In either case, the revocation notice must be received by the Company no later than 18:00 (BST) on 09 April 2024.
(m) If you attempt to revoke your proxy appointment, but the revocation is received after the time specified, your original proxy appointment will remain valid unless you attend the meeting and vote in person.
(n) A corporation which is a shareholder can appoint one or more corporate representatives who may exercise, on its behalf, all its powers as a shareholder provided that no more than one corporate representative exercises powers over the same share.
(o) As at 18:00 (BST) on 05 March 2024, which is the latest practicable date before publication of this notice, the Company's issued share capital comprised 90,729,341 ordinary shares of USD 0.01 each (made up of 90,729,339 A-shares, 1 B-share and 1 C-share).
(p) Each A and B-share carries the right to one vote on all Resolutions proposed at this Annual General Meeting. The C-share carries the right to 350,000,000 votes in respect of those matters set out in Article 4.7 of the Articles of Association but otherwise carries no right to vote. As a result, the ordinary C-share carries the right to vote on Resolutions 7 - 10 proposed at this Annual General Meeting but no right to vote on any of the other resolutions proposed at this Annual General Meeting. 493,371 A-shares are held by the Company as treasury shares and are therefore not eligible for voting. Accordingly, the total number of voting rights in the Company in respect of the Resolutions proposed at this Annual General Meeting as at 5 March 2024 is as follows:
(i) 440,235,969 votes on resolutions 7 to 10; and
(ii) 90,235,969 votes on all other resolutions.
(q) Any member attending the meeting has the right to ask questions. The Company must answer all questions related to the business being dealt with at the meeting unless:
(i) answering the question would interfere unduly with the preparation for the meeting or involve the disclosure of confidential information;
(ii) the answer has already been given on a website in the form of an answer to a question; or
(iii) it is undesirable in the interest of the Company or the good order of the meeting that the question be answered.
(r) A memorandum which outlines the key terms of the contracts for services of the Executive Director and each of the non-Executive Directors is available for inspection at the Company's registered office during normal business hours and at the place of the meeting from at least 15 minutes prior to the meeting until the end of the meeting.
(s) The quorum for the meeting is two or more members who are entitled to vote on each of the Resolutions proposed at this AGM of the Company, present in person or by proxy or a duly authorized representative of a corporation which is a member.
(t) The Ordinary Resolutions must be passed by a simple majority of the total number of votes cast for and against such Resolution. The Special Resolutions must be passed by at least 75% of the total number of votes cast for and against such resolution.
(u) At the meeting, the vote may be taken by show of hands or by poll. On a poll, every member who is present in person or by proxy shall be entitled to one vote for every share held, except for the C-share which is entitled to 350,000,000 votes in respect of those Resolutions as set out in note (p) above.
(v) If, within five minutes after the time appointed for the meeting (or such longer interval not exceeding one hour as the Chairman of the meeting may think fit to allow) a quorum is not present, the meeting shall stand adjourned to a day (but not less than ten days later, excluding the day on which the meeting is adjourned and the day for which it is reconvened), time and place to be decided by the Chairman, and at such adjourned meeting one member present in person and by proxy shall be a quorum.
(w) Pursuant to regulation 41 of The Uncertificated Securities Regulations 2001, members will be entitled to attend and vote at the meeting if they are registered on the Company's register of members at 18:00 (BST) on 09 April 2024.
TORM PLC
Registered in England and Wales – Company Number 09818726 (the "Company")
FORM OF PROXY
for use by shareholders at the Annual General Meeting to be held on 11 April 2024
I/we, the undersigned shareholder(s) of the Company hereby appoint:
1 The Chairman of the Meeting; or No. of shares:
2 ………………………………………………………………………………………………………………………………………………. (Name and address of proxy in capital letters)
as my/our proxy to vote in my/our name(s) and on my/our behalf at the Annual General Meeting of the Company to be held at Suite 105, 20 St. Dunstan’s Hill, London, EC3R 8HL, United Kingdom on 11 April 2024 at 12:00 noon (BST) and at any adjournment thereof.
Please indicate with an "X" in the appropriate boxes below how the proxy should vote and then sign on the next page. If no specific direction as to voting is given, the proxy may vote or abstain at his/her discretion.
|
|
|
ORDINARY RESOLUTIONS |
|
Resolution 1 – (Adoption of the Annual Report and accounts) |
|
Resolution 2 – (Remuneration Report) |
|
Resolution 3 – (Remuneration Policy) |
|
Resolution 4 – (Appointment of Ernst & Young LLP) |
|
Resolution 5 – (Fix remuneration of the Auditors) |
|
Resolution 6 – (Final Dividend) |
|
Resolution 7 – (Reappointment of Christopher H. Boehringer) |
|
Resolution 8 – (Reappointment of Göran Trapp) |
|
Resolution 9 – (Reappointment of Annette Malm Justad) |
|
Resolution 10 - (Reappointment of Jacob Meldgaard) |
|
Resolution 11 – (Renewal of Existing Allotment Authorities) |
|
SPECIAL RESOLUTIONS Resolution 12 - (Renewal of Existing Disapplication Authorities) Resolution 13 – (Market Purchase of Shares) Resolution 14 – (Reduction of capital) |
I/we authorize my/our proxy to act at his/her discretion in relation to any other business arising at the meeting (including in respect of whether to adjourn such meeting) and at any adjournment of such meeting.
Signature(s) ………………….................................... Dated …………………....................................
Name:...............................................(in capital letters)
Initials and surnames of joint holders if any……………………………………………………………………………….
Address ………………….................................... VP reference no.: ............................................
…………………....................................
…………………....................................
NOTES
(a) As a member of the Company, you are entitled to appoint a proxy or proxies to exercise all or any of your rights to attend, speak and vote at a general meeting of the Company. You can only appoint a proxy using the procedures set out in these notes. If the proxy is being appointed in relation to part of your holding only, please enter the number of shares in relation to which they are authorized to act as your proxy in the box next to the proxy’s name. If this box is left blank, they will be authorized in respect of your full voting entitlement.
(b) Appointment of a proxy does not preclude you from attending the meeting and voting in person. If you have appointed a proxy and attend the meeting in person, your proxy appointment will automatically be terminated.
(c) A proxy does not need to be a member of the Company but must attend the meeting to represent you. If you wish to appoint as your proxy someone other than the Chairman of the meeting, cross out the words "the Chairman of the Meeting" and write on the dotted line the full name and address of your proxy. The change should be initialed.
(d) In the case of a corporation, the proxy form must be expressed to be executed by the corporation and must be signed by a Director and the secretary or by two Directors or under the hand of a duly authorized officer or attorney.
(e) In the case of joint holders, the vote of the person first named in the register of members tendering a vote will be accepted to the exclusion of the votes of the other joint holders.
(f) You may appoint more than one proxy provided each proxy is appointed to exercise rights attached to different shares. You may not appoint more than one proxy to exercise rights attached to any one share. If you are appointing more than one proxy, please indicate the number of shares in relation to which they are authorized to act as your proxy and indicate that the proxy appointment is one of multiple appointments being made next to the proxy holder’s name. Multiple proxy appointments should be returned in the same envelope.
(g) To direct your proxy on how to vote on the resolutions, mark the appropriate box with an "X". To abstain from voting on a resolution, select the relevant "withheld" box. A vote withheld is not a vote in law, which means that the vote will not be counted in the calculation of votes for or against the resolution.
(h) In the absence of instructions, the appointed proxy may vote or abstain from voting as he or she thinks fit on the specified resolution and, unless instructed otherwise, the appointed proxy may also vote or abstain from voting as he or she thinks fit on any other business (including amendments to resolutions) which may properly come before the meeting.
(i) You are requested to complete and send this Form of Proxy (or a notarially certified copy thereof) by regular mail to the Company's registered office. To be valid, this form must be completed and deposited at the Company's registered office together with the power of attorney or other authority (if any) under which it is signed or a copy of such authority certified notarially, by 18:00 (BST) on 09 April 2024.
To: TORM Plc
APPOINTMENT OF CORPORATE REPRESENTATIVE
The company named below, being a member of your Company, hereby notifies you of the appointment of __________________________ as its Corporate Representative to attend on its behalf at the Annual General Meeting of your Company to be held on 11 April 2024 and at any adjournment thereof and to vote on the resolutions set forth in the notice of the said meeting.
Dated:
………………………………………………………
Duly authorized for and on behalf of